We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Keryx Gets Untitled Letter for Marketing Investigational Drug
Keryx Gets Untitled Letter for Marketing Investigational Drug
July 22, 2011
Keryx Biopharmaceuticals has received an FDA untitled letter for promoting a cancer’s drug’s safety and efficacy online while the product was still being investigated.